Drug

Ecnoglutide clinical trials

Also written XW003.

studies test it: 13
open now: 5
in phase 3: 7
first study started: 2021

Keep track of what changes. Save the ecnoglutide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

XW003 injection: 5
ecnoglutide: 3
Ecnoglutide Injection: 3
GLP-1 analogue: 2
Ecnoglutide high dosage: 2

Development codes

XW003: 4
XW004: 1

Studies by the year they started

13 studies that test it; most in 2026 (4)

Studies that test ecnoglutide, by start year
Year	Studies
2021	1
2022	2
2023	3
2025	3
2026	4

By phase

A phase 1/2 study counts in both.

Phase 1: 4
Phase 2: 3
Phase 3: 7

What it is tested for

Each study’s main condition, where its own words name it.

Obesity: 7
Diabetes Mellitus, Type 2: 2
Sleep Apnea, Obstructive: 2
Osteoarthritis, Knee: 1

Who runs them

Industry 13 · Other 0

Hangzhou Sciwind Biosciences Co., Ltd. (11) · Sciwind Biosciences APAC CO Pty. Ltd. (2)

Often tested with

Tested in the same studies.

Metformin (1) · Warfarin (1) · Rosuvastatin (1) · Digoxin (1)

Studies

Open first, then newest update. How each study uses ecnoglutide is read from its arms, and is right about nine times in ten.

Testing it · 13

Codes

What other systems call ecnoglutide · ClinicalTrials.gg INT017079

UNII (FDA) KM6YM7L8LHECNOGLUTIDEConfirmed FDA, Wikidata
Wikidata Q123481340ecnoglutideConfirmed FDA, Wikidata
NCI Thesaurus C188592EcnoglutideOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	KM6YM7L8LH	ECNOGLUTIDE	Confirmed FDA, Wikidata
Wikidata	Q123481340	ecnoglutide	Confirmed FDA, Wikidata
NCI Thesaurus	C188592	Ecnoglutide	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.